🇺🇸 FDA
Pipeline program

fluticasone/salmeterol, tiotropium

140420

Approved small_molecule active

Quick answer

fluticasone/salmeterol, tiotropium for COPD is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
COPD
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials